These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1023 related articles for article (PubMed ID: 17582498)
1. One-year outcomes of photodynamic therapy in age-related macular degeneration and polypoidal choroidal vasculopathy in Japanese patients. Gomi F; Ohji M; Sayanagi K; Sawa M; Sakaguchi H; Oshima Y; Ikuno Y; Tano Y Ophthalmology; 2008 Jan; 115(1):141-6. PubMed ID: 17582498 [TBL] [Abstract][Full Text] [Related]
2. Selective photodynamic therapy for neovascular age-related macular degeneration with polypoidal choroidal neovascularization. Eandi CM; Ober MD; Freund KB; Slakter JS; Yannuzzi LA Retina; 2007 Sep; 27(7):825-31. PubMed ID: 17891004 [TBL] [Abstract][Full Text] [Related]
3. Photodynamic therapy with verteporfin for symptomatic polypoidal choroidal vasculopathy: one-year results of a prospective case series. Chan WM; Lam DS; Lai TY; Liu DT; Li KK; Yao Y; Wong TH Ophthalmology; 2004 Aug; 111(8):1576-84. PubMed ID: 15288991 [TBL] [Abstract][Full Text] [Related]
4. Indocyanine green angiography: guided photodynamic therapy for polypoidal choroidal vasculopathy. Otani A; Sasahara M; Yodoi Y; Aikawa H; Tamura H; Tsujikawa A; Yoshimura N Am J Ophthalmol; 2007 Jul; 144(1):7-14. PubMed ID: 17467649 [TBL] [Abstract][Full Text] [Related]
5. Use of fluorescein and indocyanine green angiography in polypoidal choroidal vasculopathy patients following photodynamic therapy. Windisch R; Windisch BK; Cruess AF Can J Ophthalmol; 2008 Dec; 43(6):678-82. PubMed ID: 19020634 [TBL] [Abstract][Full Text] [Related]
6. Refractory neovascular age-related macular degeneration secondary to polypoidal choroidal vasculopathy. Cho M; Barbazetto IA; Freund KB Am J Ophthalmol; 2009 Jul; 148(1):70-8.e1. PubMed ID: 19403115 [TBL] [Abstract][Full Text] [Related]
8. Two-year visual outcomes after photodynamic therapy in age-related macular degeneration patients with or without polypoidal choroidal vasculopathy lesions. Tsuchiya D; Yamamoto T; Kawasaki R; Yamashita H Retina; 2009; 29(7):960-5. PubMed ID: 19491727 [TBL] [Abstract][Full Text] [Related]
9. Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization--verteporfin in photodynamic therapy report 2. Verteporfin In Photodynamic Therapy Study Group Am J Ophthalmol; 2001 May; 131(5):541-60. PubMed ID: 11336929 [TBL] [Abstract][Full Text] [Related]
10. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials--TAP report. Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study Group. Arch Ophthalmol; 1999 Oct; 117(10):1329-45. PubMed ID: 10532441 [TBL] [Abstract][Full Text] [Related]
11. Comparative assessment of photodynamic therapy for typical age-related macular degeneration and polypoidal choroidal vasculopathy: a multicenter study in Hyogo prefecture, Japan. Honda S; Imai H; Yamashiro K; Kurimoto Y; Kanamori-Matsui N; Kagotani Y; Tamura Y; Yamamoto H; Ohoto S; Takagi H; Uenishi M; Negi A Ophthalmologica; 2009; 223(5):333-8. PubMed ID: 19478533 [TBL] [Abstract][Full Text] [Related]
12. Photodynamic therapy with verteporfin for age-related macular degeneration or polypoidal choroidal vasculopathy: comparison of the presence of serous retinal pigment epithelial detachment. Saito M; Iida T; Nagayama D Br J Ophthalmol; 2008 Dec; 92(12):1642-7. PubMed ID: 18782798 [TBL] [Abstract][Full Text] [Related]
13. Long-term follow-up of polypoidal choroidal vasculopathy after photodynamic therapy with verteporfin. Sayanagi K; Gomi F; Sawa M; Ohji M; Tano Y Graefes Arch Clin Exp Ophthalmol; 2007 Oct; 245(10):1569-71. PubMed ID: 17437122 [TBL] [Abstract][Full Text] [Related]